AstraZeneca is good as a booster vs. omicron

AstraZeneca, COVID-19 shots, preliminary data from the Vaxzevria study, when given as a third booster immunotherapy, more against the Omicron variant and others containing beta, delta, alpha, gamma. It is said to indicate that it produces a high antibody response.

An increase in response was seen in people previously vaccinated with either the Vaxzevria or mRNA vaccine, and added that this data would be submitted to regulators worldwide, given the urgent need for boosters.

AstraZeneca has developed a vaccine with researchers at Oxford University. A laboratory study last month found that a three-dose course of Vaxzevria was effective against a rapidly expanding new variant.

This data was first released by the company from a vaccine booster test.

The company said there was increasing evidence to support a third dose of the vaccine, regardless of the primary vaccination schedule.

“These important studies show that a second dose of the same vaccine, or a third dose of Vaxzevria after the mRNA or inactivated vaccine, strongly boosts immunity to COVID-19.” Oxford Vaccine Group Chief Andrew Pollard said in a statement Thursday.

A major UK study in December found that AstraZeneca shots increased antibodies when given as a booster after the first vaccination of Pfizer based on a proprietary shot or mRNA technology.

However, the study concluded that the mRNA vaccine produced by Pfizer and Moderna provides maximum boost to the antibody when administered as boost.

AstraZeneca is good as a booster vs. omicron

Source link AstraZeneca is good as a booster vs. omicron

Related Articles

Back to top button